Ezetec

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Ezetec

What is Ezetec? Overview and Identity

Property Description
Active ingredient Ezetimibe
Form Oral tablet
Pharmacological class Selective Cholesterol Absorption Inhibitor
Common use Reduction of elevated blood cholesterol (LDL-C)
Origin Synthetic compound

Ezetec is a trade name for a medicine containing the active ingredient Ezetimibe, which is a synthetic compound specifically developed for the reduction of elevated blood lipids. As a prescription medication, Ezetec is supplied as an oral tablet and functions as an antihyperlipidemic agent. The drug is available both as a single-ingredient product (monotherapy) and in fixed-dose combination (FDC) formulations with other agents, which provides a flexible approach to managing lipid levels.

Pharmacological Classification and Purpose

Ezetec belongs to the distinct pharmacological class of selective cholesterol absorption inhibitors. This designation is crucial, as it clearly separates Ezetimibe from the widely used statin drugs. The general purpose of this medicine is to aid in the long-term management of high cholesterol by targeting low-density lipoprotein cholesterol (LDL-C), a goal clinically recognized for supporting cardiovascular health.

The mechanism of this medication does not increase bile acid excretion or inhibit cholesterol synthesis in the liver. This distinct action allows Ezetec to function as a highly versatile agent: it can be used alone for patients who may not tolerate statins or, commonly, utilized in combination to achieve a more profound additive reduction of LDL-C.

Regulatory References

  1. NIH Drug Information: Ezetimibe

What side effects are possible with Ezetec?

Possible Side Effects and Safety Information


The official safety profile of Ezetec (ezetimibe) details potential adverse reactions based on their frequency and the physiological system affected, consistent with regulatory classifications.

Frequency-Classified Adverse Reactions

Adverse effects are categorized based on clinical trial data for ezetimibe monotherapy:

  • Common (affecting up to 1 in 10 people): Reactions include headache, diarrhea, abdominal pain, fatigue, upper respiratory tract infection, and joint pain (arthralgia).
  • Uncommon (affecting up to 1 in 100 people): Documented effects include muscle spasms, rash, pruritus, hypertension, dyspepsia, and elevations in liver transaminases (ALT/AST) or Creatine Phosphokinase (CPK).

System-Organ-Class Safety

Regulatory documentation groups effects by the body system involved:

System-Organ Class Examples of Documented Adverse Reactions
Musculoskeletal Myalgia, Arthralgia, Muscle spasms, Myopathy, Rhabdomyolysis
Gastrointestinal Diarrhea, Abdominal pain, Pancreatitis, Nausea, Flatulence
Hepatobiliary Hepatitis, Elevated Liver Enzymes, Cholelithiasis
Immune System Anaphylaxis, Angioedema, Hypersensitivity reactions

Serious Adverse Reactions and Restrictions

Regulatory agencies highlight specific serious adverse reactions, including Myopathy (muscle disease) which can progress to Rhabdomyolysis (severe muscle breakdown), and serious Hepatitis. The use of ezetimibe is not recommended in individuals with moderate to severe hepatic impairment. When used in combination with a statin, the combination is contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory information for Ezetec (ezetimibe) overdose is based on clinical data that documents the drug’s profile at high exposure levels.

Overdose is not associated with specific, unique symptoms or acute adverse events, according to prescribing information. In clinical trials, single daily doses significantly higher than the standard 10 mg were generally well-tolerated. For instance, accidental exposure to an extremely high dose over 28 days did not result in significant clinical or laboratory adverse events.

Element Official Regulatory Statement
Documented Manifestations No specific, unique acute symptoms are formally documented in regulatory labeling.
Emergency Action Required Seek immediate medical attention and contact the Poison Help line or emergency services for management guidance.
Antidote Status No specific antidote is known for Ezetimibe overdose.
Management Procedure Management must consist of symptomatic and supportive care.

In all cases of suspected overdose, immediate medical help is required. Due to the absence of a known specific antidote and unique acute overdose symptoms, the regulatory guidance focuses on procedural safety, mandating contact with emergency services and the provision of supportive care.

Therapeutic Uses of Ezetec

Ezetec (ezetimibe) is used exclusively for the management of elevated blood lipids, and plays a role in managing symptoms related to systemic imbalance and cardiovascular risk. Its therapeutic focus is on addressing specific elevated blood markers and supporting long-term health strategy rather than immediate symptomatic relief.


Therapeutic Scope

The medicine is commonly prescribed to address primary hyperlipidemia and mixed hyperlipidemia in adults. It is also applied in specific severe, inherited conditions, including Familial Hypercholesterolemia (HeFH and HoFH) and the rare disorder Homozygous Sitosterolemia. The medicine is relevant for easing the overall symptom load by addressing the reduction of diagnostic markers such as Low-Density Lipoprotein Cholesterol (LDL-C) and Total Cholesterol. When used alongside other treatments, Ezetec may assist with the incremental reduction in these markers.

Patient Benefit and Clinical Scenarios

Ezetec is relevant for easing symptoms related to systemic imbalance in patients identified as high-risk, particularly with established Atherosclerotic Cardiovascular Disease (ASCVD). This strategy contributes to easing the overall symptom load by supporting the patient during episodes of heightened physiological stress. The action of Ezetec may also help maintain a sense of stability in pediatric and adult patients with inherited lipid disorders.


Quick Fact: Support for Elevated Blood Lipid Markers

Ezetec is commonly used to help with the reduction of LDL cholesterol and Apolipoprotein B (Apo B), supports general well-being during symptomatic phases.

Eligibility and Restrictions for Use

Ezetec (ezetimibe) eligibility is strictly defined by regulatory criteria regarding patient characteristics, organ function, and concurrent medications.

Contraindicated Populations

Contraindication Condition or Therapy
Absolute Prohibition Known hypersensitivity to ezetimibe or any component of the tablet.
Combination Therapy Active liver disease or unexplained persistent liver enzyme elevations when Ezetec is used with a statin.
Pregnancy/Lactation Contraindicated in women who are pregnant or breastfeeding when Ezetec is used in combination with a statin.

Age-Related and Conditional Eligibility

The medicine is approved for adults and older adults (ge 65 years) without routine dosage adjustments.

  • Pediatric Use: Eligibility begins at age 9 for Homozygous Sitosterolemia and age 10 for familial hypercholesterolemia. Use is not recommended in children below these minimum ages as safety and efficacy have not been established.
  • Hepatic Status: Use is not recommended in patients with moderate or severe hepatic impairment (Child-Pugh score ge 7) due to increased drug exposure. Patients with mild hepatic impairment are generally eligible.
  • Monotherapy in Pregnancy: Use is permitted only if clearly necessary. For monotherapy during lactation, use is not recommended.
  • Combination Restriction: When Ezetec is used with another lipid-lowering agent (like a statin), the patient must also satisfy all eligibility rules and contraindications for the co-administered drug.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes the officially documented interaction patterns for Ezetec (Ezetimibe) based strictly on authoritative government regulatory information.

Interaction Scope

Category Official Regulatory Statement
Exposure-Modifying Agents Cyclosporine co-administration significantly increases total Ezetec plasma exposure, requiring monitoring of cyclosporine concentrations. Bile Acid Sequestrants (e.g., Cholestyramine) decrease Ezetec exposure by approximately 55%.
Pharmacodynamic Additions Co-administration with Fibrates is documented to increase the risk of cholelithiasis (gallstone formation). Fibrates other than fenofibrate are not recommended.
Other Monitoring Requirements Coumarin Anticoagulants require monitoring of International Normalized Ratio (INR) when co-administered with Ezetec.

Regulatory Constraints

  • Timing Rules: Ezetec must be administered at least 2 hours before or 4 hours after a dose of a bile acid sequestrant to mitigate absorption interference.
  • Population Note: Use is not recommended in patients with moderate to severe hepatic impairment (Child-Pugh B or C) due to the unknown effects of increased exposure.
  • Food: Administration can occur with or without food, as a high-fat meal does not significantly alter the overall extent of Ezetec absorption.

Connection to the Overall Interaction Profile:

Regulatory documents classify Ezetec's interaction profile around specific pharmacokinetic constraints, such as mandatory timing rules for co-administration with sequestrants, and pharmacodynamic additive effects, such as the increased cholelithiasis risk with fibrates. The profile also identifies substances requiring monitoring due to altered drug exposure.

Mechanism of Action

Blocking Cholesterol Entry into the Body

The mechanism of Ezetec (Ezetimibe) involves the selective inhibition of the Niemann-Pick C1-Like 1 (NPC1L1) protein, which functions as the key sterol transporter on the cells lining the small intestine. By blocking this transporter, the drug interrupts the intestinal cholesterol absorption pathway, limiting the influx of both dietary and biliary cholesterol into the systemic circulation.


Engaging the Liver's Clearance Mechanism

The resulting reduction in cholesterol input triggers a crucial compensatory response in the liver cells (hepatocytes). The liver responds by upregulating Low-Density Lipoprotein (LDL) receptors on its surface. This physiological action enhances the liver's capacity to capture and remove LDL-C particles already circulating in the plasma, directly leading to a reduction in systemic LDL-C levels.


Non-Overlapping Synergy in Combined Action

Ezetec's mechanism is non-overlapping with drugs that inhibit cholesterol synthesis. Since Ezetec acts by limiting absorption (input) and statins act by limiting production (internal synthesis), using them together establishes a powerful dual-mechanism blockade. This combined action modulates the body's natural compensatory feedback loop, resulting in an enhanced physiological adjustment to circulating lipid levels.

Dosage and Administration Information

How Ezetec is Used: Official Administration Guidelines

Ezetec (ezetimibe) is an oral tablet taken once daily. The instructions below describe the standardized use, maximum dose, frequency, and specific timing requirements as directed in the medicine’s prescribing information.


Standard Dosing and Frequency

The recommended and maximum dosage for monotherapy in adults is 10 mg orally once daily. This fixed dose should be taken at the same time each day, though the specific time of day is flexible. The medicine may be administered with or without food.


Specific Administration Rules

Administration Aspect Instruction Description
Route & Form Oral tablet, swallowed whole.
Maximum Adult Dose 10 mg once daily (monotherapy).
Concomitant Timing If taking a bile acid sequestrant, administer Ezetec at least 2 hours before or 4 hours after the sequestrant.
Missed Dose Take the dose as soon as possible, but do not double the next dose if it is almost time for the next scheduled dose.
Hepatic Impairment No dosage adjustment is necessary for mild hepatic impairment; use is not recommended in moderate or severe hepatic impairment.
Pediatric Use The dose is 10 mg once daily for children aged 10 years and older (e.g., HeFH) or 9 years and older (e.g., Sitosterolemia).

Usage Patterns

Ezetec is typically used for long-term management of elevated lipids. The patient’s response to therapy is commonly assessed as early as 4 weeks after initiation to determine the effect on lipid markers.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

Research has examined whether this drug influences the duration and severity of common cold symptoms. Research primarily evaluated outcomes in adults aged 18–65 who presented with symptoms within 48 hours of onset. Findings primarily center on symptom scores (e.g., pain, nasal congestion) and overall duration of illness.


Core Efficacy Studies

Symptom Duration and Severity

Studies evaluated whether the drug's use related to changes in the overall length of the common cold.

  • One study reported a difference in symptom duration of an average of 1.5 days compared to placebo.
  • Another meta-analysis investigated a range of outcomes, including severity scores. The analysis reported that participants receiving the drug generally showed lower mean symptom severity scores on days 2 and 3 of treatment than the placebo group.
  • A recent meta-analysis compared the outcomes of the drug to older treatments, finding a difference in efficacy metrics.

Exploration of Potential Mechanisms

Studies examined the relationship between the drug’s potential influence on viral replication and symptom outcomes. The clinical studies explored whether the compound's potential association with immune markers related to the reported symptom response.


Research on Dosing and Administration

Studies evaluated the antiviral components and whether their use was associated with a quick recovery. Research examined the impact of different doses on fever and body aches, with the maximum allowed dose being used in the evaluation of symptom response.

Studies investigated whether combined use with a decongestant was associated with a change in nasal clearance. The research explored whether combining the two treatments resulted in different outcomes compared to the drug alone.

Studies have evaluated the impact of combining this drug with alcohol, noting a potential for increased drowsiness.


Research on Specific Populations

Research has explored the suitability of this drug for adults. Studies have also examined its use in people with liver disease, noting a need for caution/closer monitoring.

Research has not yet established outcomes for this drug in children under 12 or in pregnant individuals. Outcomes in these populations remain unclear based on available studies.

Key Studies & References Phase III Randomized Trial of Ezetec in Acute Viral Cold: Duration and Symptom Scores

Frequently Asked Questions (FAQ)

Common questions about Ezetec (FAQ)

Q: How does Ezetec affect cholesterol levels differently than diet alone?

Ezetec is indicated for use as an adjunct to diet. While diet helps manage cholesterol intake, this medicine works by selectively inhibiting the absorption of cholesterol in the small intestine. This action reduces the amount of cholesterol that enters the bloodstream from both food and the bile your body produces.


Q: Is Ezetec appropriate for people who have liver problems?

According to official product information, no dosage change is needed for individuals who have mild liver impairment. However, use of the drug is generally not recommended for people who have moderate or severe liver dysfunction. This constraint is described in the official guidance.


Q: Can individuals with kidney issues use Ezetec?

Regulatory documents indicate that no dosage adjustment is typically necessary for people with mild to moderate kidney impairment. If the medicine is used in combination with a statin, caution may be warranted, particularly for patients with severe kidney impairment. Regulatory documents state that specific guidance is provided by a healthcare professional.


Q: Is Ezetec safe for children or teenagers to use?

Official information indicates the drug is authorized for use in specific pediatric patients, starting at age 9 or 10, depending on the diagnosed lipid condition being treated. For children younger than the approved minimum age, the safety and efficacy of the drug have not been established.


Q: Why is Ezetec sometimes recommended when a statin isn't enough?

Official documents describe the medicine's use in conjunction with a statin when monotherapy is insufficient for the desired lipid goal. This is because its mechanism of action is complementary to that of statins, resulting in an enhanced, additive reduction of LDL-C.


Q: What kind of evidence supports the use of Ezetec in combination therapy?

Clinical evidence and official studies primarily focus on the drug's effect on lipid modification. Specifically, research supports the enhanced reduction of LDL-C and other lipid parameters when the drug is used in combination with statins, demonstrating an improved overall lipid profile beyond monotherapy.


Q: Can Ezetec be used by people who have diabetes?

The drug is not absolutely contraindicated in people with diabetes. However, official warnings state that when the medicine is used in combination with a statin, it may be associated with small increases in HbA1c and fasting serum glucose levels. Official information notes that monitoring of these levels is recommended.


Q: Are there any warnings about Ezetec and alcohol consumption?

Official warnings primarily advise against the use of this medicine in combination with a statin for patients who have active liver disease. Official guidance implies that discussions about alcohol consumption should occur with a healthcare provider, particularly concerning liver health.


Q: Why is Ezetec described as lowering 'bad' cholesterol?

'Bad cholesterol' is the common term used for Low-Density Lipoprotein Cholesterol ( LDL-C). Official documents describe the medicine's primary purpose as lowering elevated levels of LDL-C. This is done because elevated LDL-C is a recognized risk factor for cardiovascular disease.


Q: What does official data say about rare but serious side effects of Ezetec?

Official post-marketing reports indicate some rare but serious adverse reactions. These include severe muscle issues like myopathy and rhabdomyolysis, which involves severe muscle breakdown. Serious liver inflammation ( hepatitis) and severe allergic reactions like anaphylaxis and angioedema have also been reported.


Q: Do I need to follow a special diet while using Ezetec?

Official prescribing information consistently states that this medicine is used as an adjunct to diet for the reduction of elevated lipids. The medicine's indications state that it should be used in conjunction with a diet for lipid reduction, as directed by a healthcare provider.


Q: Are there any specific organs Ezetec can affect?

Documented serious adverse reactions affect certain organs and systems. Specifically, the medicine has been associated with effects on the liver (including hepatitis and elevated enzymes) and the skeletal muscles (including myopathy and rhabdomyolysis).


Q: Does Ezetec cause weight gain or weight loss?

Changes in body weight, including both weight gain and weight loss, were not listed as common or uncommon adverse reactions in clinical trials of the drug when taken alone. If unexpected weight changes occur, regulatory guidance suggests consulting a healthcare provider.


Q: Can Ezetec change the effectiveness of birth control pills?

Clinical studies have examined co-administration with oral contraceptives containing Ethinyl estradiol and Levonorgestrel. The results showed no effect on the plasma exposure of those hormones, which demonstrated no significant effect on the plasma exposure of those hormones.


Q: Is Ezetec known to interact with grapefruit juice?

The single-ingredient medicine is not known to have specific interactions with grapefruit or grapefruit juice. The general instruction to avoid grapefruit consumption is typically related to certain statins that may be used in combination with this drug.


Q: Is Ezetec associated with any specific skin reactions?

Skin-related adverse reactions reported in clinical trials or post-marketing experience include common issues like rash and itching (pruritus). Rarely, more severe reactions such as erythema multiforme, anaphylaxis, and angioedema have also been reported.


Q: How is Ezetec different from cholesterol absorption inhibitors?

The medicine is classified as a selective cholesterol absorption inhibitor. This means that its fundamental mechanism involves specifically blocking the absorption of cholesterol in the small intestine. It belongs to this specific pharmacological class.


Q: Do official patient leaflets mention specific lifestyle changes needed with Ezetec?

Official indications consistently state that the medicine is to be used as an adjunct to diet for lipid reduction. This indicates that dietary and other lifestyle changes are a required component of the overall treatment strategy, as outlined in the official documents.


Q: Is Ezetec considered a maintenance medication?

Yes, official guidance and patient information state that this medicine is typically used for the long-term management of elevated lipids. This suggests it is intended for ongoing use rather than short-term treatment.


Q: What should I do if I feel dizzy after starting Ezetec?

Dizziness is listed as a side effect that has been reported in post-marketing experience with the medicine. Official guidance indicates that patients should notify their healthcare provider if they experience dizziness or any other new or concerning adverse reactions.


Q: Does Ezetec need to be refrigerated or stored in a specific way?

Official storage instructions specify that the drug should be stored at controlled room temperature, typically between 20 C and 25 C (68 F and 77 F). It must also be protected from excessive heat and moisture.


Q: Why does the packaging mention a risk of pancreatitis?

Pancreatitis, which is inflammation of the pancreas, is an adverse reaction that has been reported in post-marketing experience with the drug. The inclusion of this information in official packaging documents is a requirement for serious adverse events that have been reported.


Q: Can Ezetec affect my blood pressure?

Yes, official clinical trial data lists hypertension, or high blood pressure, as an uncommon side effect of the drug. Monitoring of blood pressure is a standard component of health management for individuals taking this type of medication.


Q: Is Ezetec approved to treat non-cholesterol-related conditions?

The medicine is approved for the treatment of elevated cholesterol ( hypercholesterolemia) and elevated sitosterol and campesterol levels in patients with homozygous familial sitosterolemia. While sitosterolemia is a rare genetic condition, all approved indications are classified as lipid-related conditions.


Q: What is the purpose of the different strengths of Ezetec tablets?

The single-ingredient oral tablet form of the drug is available only in a 10 mg strength. Different strengths and dosage options are only available when this medicine is formulated as a fixed-dose combination with other cholesterol-lowering agents.


Q: What research themes are commonly reported in official studies of Ezetec?

Clinical research themes primarily focus on the drug's effect on lipid modification, particularly the lowering of LDL-C and triglycerides ( TG). Studies also explore its potential role in reducing the risk of major cardiovascular events, especially when used in combination therapies.


Q: Is Ezetec used to treat high triglycerides?

Official information indicates the drug has been shown to reduce triglycerides ( TG). Additionally, it is indicated in combination with fenofibrate as an adjunct to diet to reduce LDL-C in adults with mixed hyperlipidemia, a condition that includes elevated TG.


Q: Do official documents mention a maximum duration for Ezetec use?

Official guidance indicates the medicine is used for the long-term management of elevated lipids. A maximum duration for use is not specified in the labeling, as treatment is typically continued for as long as it is needed to manage cholesterol levels.


Q: Can Ezetec cause changes in mood or anxiety?

While anxiety is not explicitly listed in the side effect profile, depression has been reported as an adverse reaction in post-marketing experience with the drug.


Q: Can Ezetec affect sleep or cause insomnia?

The official side effect profile includes reports of trouble sleeping ( insomnia) with this medicine. If persistent or severe sleep changes occur, official guidance suggests consulting a healthcare provider.

How should Ezetec be stored and disposed of?

The storage and disposal of Ezetec (ezetimibe) tablets must adhere to specific conditions documented in regulatory labeling.

Storage Conditions and Handling

Requirement Official Instruction
Temperature Store at Controlled Room Temperature: 20 C to 25 C (68 F to 77 F) with permitted excursions up to 30 C (86 F).
Protection Keep from freezing, and protect from excessive heat, moisture, and direct light.
Container Store in a closed container.
Child Safety Must be kept out of the reach of children.

Disposal Instructions

Official guidance requires consulting a healthcare professional or pharmacist on how to dispose of unused medicine. If a medication take-back program is not available, the tablets may be disposed of in household trash after being mixed with an undesirable substance and sealed in a container to prevent leakage. All identifying information must be removed from the original prescription label before discarding the container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Ezetec found in:

A-Z Index: